Prospective Trial of a Novel Nomogram to Achieve Updated Vancomycin Trough Concentrations

Purpose. To determine if the use of a novel vancomycin nomogram predicts dosing regimens that achieve target trough concentrations equal to or more accurate than dosing regimens calculated using traditional pharmacokinetic calculations, evaluate the incidence of subtherapeutic and supratherapeutic t...

Full description

Saved in:
Bibliographic Details
Main Authors: Amber R. Wesner, Marcia L. Brackbill, Larissa L. Coyle, Robert S. Kidd
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Interdisciplinary Perspectives on Infectious Diseases
Online Access:http://dx.doi.org/10.1155/2013/839456
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549247704104960
author Amber R. Wesner
Marcia L. Brackbill
Larissa L. Coyle
Robert S. Kidd
author_facet Amber R. Wesner
Marcia L. Brackbill
Larissa L. Coyle
Robert S. Kidd
author_sort Amber R. Wesner
collection DOAJ
description Purpose. To determine if the use of a novel vancomycin nomogram predicts dosing regimens that achieve target trough concentrations equal to or more accurate than dosing regimens calculated using traditional pharmacokinetic calculations, evaluate the incidence of subtherapeutic and supratherapeutic troughs, and assess pharmacist's impressions of the nomogram. Methods. Prospective, open-label study in 473 patients who had a new order for vancomycin and were >18 years of age and ≤120 kg. Patients were randomized to the active group, dosed using the nomogram, or to the control group, dosed using traditional pharmacokinetic calculations already in place at our institution. Results. Patients dosed via nomogram were within the appropriate trough range in 44% of cases compared to 33% in the control group (P=0.014). Vancomycin troughs less than 10 mcg/mL were significantly decreased with the use of nomogram (P=0.032). Incidence of supratherapeutic troughs, greater than 20 mcg/mL, was not significantly different between groups (P=0.706), and pharmacists agreed that the nomogram was easy to use and saved their time. Conclusions. A novel vancomycin nomogram was prospectively validated and found to be more effective than traditional pharmacokinetic dosing. The nomogram is being implemented as the standard dosing protocol at our institution.
format Article
id doaj-art-9f032cac19194b549d8d0763d060917d
institution Kabale University
issn 1687-708X
1687-7098
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Interdisciplinary Perspectives on Infectious Diseases
spelling doaj-art-9f032cac19194b549d8d0763d060917d2025-02-03T06:11:42ZengWileyInterdisciplinary Perspectives on Infectious Diseases1687-708X1687-70982013-01-01201310.1155/2013/839456839456Prospective Trial of a Novel Nomogram to Achieve Updated Vancomycin Trough ConcentrationsAmber R. Wesner0Marcia L. Brackbill1Larissa L. Coyle2Robert S. Kidd3Department of Pharmacy Practice, Shenandoah University, 1775 North Sector Court, Winchester, VA 22601, USADepartment of Pharmacy Practice, Shenandoah University, 1775 North Sector Court, Winchester, VA 22601, USADepartment of Pharmacy, Winchester Medical Center, 1840 Amherst Street, Winchester, VA 22601, USADepartment of Biopharmaceutical Sciences, Shenandoah University, 1775 North Sector Court, Winchester, VA 22601, USAPurpose. To determine if the use of a novel vancomycin nomogram predicts dosing regimens that achieve target trough concentrations equal to or more accurate than dosing regimens calculated using traditional pharmacokinetic calculations, evaluate the incidence of subtherapeutic and supratherapeutic troughs, and assess pharmacist's impressions of the nomogram. Methods. Prospective, open-label study in 473 patients who had a new order for vancomycin and were >18 years of age and ≤120 kg. Patients were randomized to the active group, dosed using the nomogram, or to the control group, dosed using traditional pharmacokinetic calculations already in place at our institution. Results. Patients dosed via nomogram were within the appropriate trough range in 44% of cases compared to 33% in the control group (P=0.014). Vancomycin troughs less than 10 mcg/mL were significantly decreased with the use of nomogram (P=0.032). Incidence of supratherapeutic troughs, greater than 20 mcg/mL, was not significantly different between groups (P=0.706), and pharmacists agreed that the nomogram was easy to use and saved their time. Conclusions. A novel vancomycin nomogram was prospectively validated and found to be more effective than traditional pharmacokinetic dosing. The nomogram is being implemented as the standard dosing protocol at our institution.http://dx.doi.org/10.1155/2013/839456
spellingShingle Amber R. Wesner
Marcia L. Brackbill
Larissa L. Coyle
Robert S. Kidd
Prospective Trial of a Novel Nomogram to Achieve Updated Vancomycin Trough Concentrations
Interdisciplinary Perspectives on Infectious Diseases
title Prospective Trial of a Novel Nomogram to Achieve Updated Vancomycin Trough Concentrations
title_full Prospective Trial of a Novel Nomogram to Achieve Updated Vancomycin Trough Concentrations
title_fullStr Prospective Trial of a Novel Nomogram to Achieve Updated Vancomycin Trough Concentrations
title_full_unstemmed Prospective Trial of a Novel Nomogram to Achieve Updated Vancomycin Trough Concentrations
title_short Prospective Trial of a Novel Nomogram to Achieve Updated Vancomycin Trough Concentrations
title_sort prospective trial of a novel nomogram to achieve updated vancomycin trough concentrations
url http://dx.doi.org/10.1155/2013/839456
work_keys_str_mv AT amberrwesner prospectivetrialofanovelnomogramtoachieveupdatedvancomycintroughconcentrations
AT marcialbrackbill prospectivetrialofanovelnomogramtoachieveupdatedvancomycintroughconcentrations
AT larissalcoyle prospectivetrialofanovelnomogramtoachieveupdatedvancomycintroughconcentrations
AT robertskidd prospectivetrialofanovelnomogramtoachieveupdatedvancomycintroughconcentrations